13D Filing: Adage Capital Management and Inotek Pharmaceuticals Corp (ITEK)

Page 12 of 13

Page 12 of 13 – SEC Filing

Schedule A

This Schedule sets forth
information with respect to each purchase and sale of shares of Common Stock which were effectuated by ACP within the past sixty
days and. All transactions were effectuated in the open market through a broker. The price reported in the column Price Per Share
($) is a weighted average price if a price range is indicated in the column Price Range ($). These Ordinary Shares were purchased/sold
in multiple transactions at prices between the price ranges below. The Reporting Persons will undertake to provide to the staff
of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price.

Trade Date Shares Purchased (Sold) Price Per Share ($)* Price Range ($)
09/14/2017 162,552 1.19 1.145-1.21
09/15/2017 123,600 1.32 1.25-1.39
09/18/2017   68,000 1.35 1.33-1.35
09/19/2017   49,106 1.30 1.26-1.315
09/20/2017   43,691 1.40 1.365-1.4
09/21/2017 126,999 1.49 1.46-1.5
09/22/2017 106,052 1.49 1.46-1.5
09/25/2017 111,809 1.60 1.555-1.6
09/26/2017 100,000 1.73 1.705-1.75
09/27/2017   53,191 1.68 1.66-1.7
09/28/2017   85,000 1.69 1.66-1.74

*       Excluding
commissions.

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Page 12 of 13